AbbVie Inc. — Director's Dealing 2016

Feb 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2016-02-05

Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-05	Common stock, $0.01 par value	M	3400	$22.9407	Acquired	5143	Indirect
2016-02-05	Common stock, $0.01 par value	F	2112	$56.76	Disposed	3031	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-05	Option (right to buy)	$22.9407	M	3400	Disposed	2016-02-16	Common stock (3400)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	99963	Direct
Common stock, $0.01 par value	1795	Indirect

Footnotes

F1: Balance in the AbbVie Savings Program as of February 5, 2016.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.